TURKCELL ILETISIM HIZMETLERI AS AND ITS SUBSIDIARIES CONSOLIDATED CASH FLOW* ANALYSIS

 

*The consolidated financial statements have been prepared in accordance with International Financial Reporting Standards.

(000) US$ except share amounts	Nine Months ended 30 September 2008	Nine months ended 30 September 2007	Change %
Profit for the period	1,517,966	913,739	66.1%
Net cash from operating activities	1,078,771	1,598,780	-32.5%
Net cash used in investing activities	-595,440	-244,478	143.6%
Net cash used in financing activities	-398,022	-280,135	42.1%
Effects of foreign exchange rate fluctuations on balance sheet items	-163,059	104,271	-256.4%
Net increase in cash and cash equivalents	-77,750	1,298,787	-106.0%
Cash and cash equivalents at 1 January	3,093,175	1,598,356	93.5%
Effect of exchange rate fluctuations on cash and cash equivalents	71,713	-382,615	-118.7%
Cash and cash equivalents at 30 June	3,087,138	2,514,528	22.8%